← Eichor
Study identifier: NCT07143266 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sleep Disorders in Hypothalamic and Pituitary Damage

Condition: Hypopituitarism · Sleep Wake Disorders · Hypothalamic Diseases  ·  Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

Hypothalamus has a key role in multiple vital functions, including regulation of sleep-wake cycles. Oxytocin (OT), a neurohormone synthetized in the hypothalamus, has a wide range of physiological functions, including a putative role in improving sleep quality. Hypothalamic and pituitary damage (HPD) is associated with a clinically relevant OT deficient state and multiple and severe comorbidities including poor sleep quality, that have a well-known negative impact on general health and quality of life (QoL). Several factors may coexist in the pathophysiology of sleep disorders (SD) in HPD and SD might be a keystone in the persistence of some of the comorbidities observed in HPD. Therefore, appropriate identification and understanding of the mechanisms contributing to SD in HPD is mandatory to choose adequate preventive strategies and treatment. This project is aimed to (1) identify the prevalence of SD in HPD, (2) to determine OT role in sleep quality and (3) to identify potential mechanisms and mediators of sleep quality and their associations with clinical outcomes in patients with HPD with the ultimate goal of identifying preventive and therapeutic targets. We will use a controlled cross-sectional design of patients with HPD and sex-, BMI-, age- matched controls and an innovative cross-disciplinary approach bridging neuroendocrinology, psychology, neurophysiology, neuroimaging, nuclear medicine and neuroophthalmology disciplines to learn about the prevalence of SD in HPD a…

This description comes directly from the study's public registry record.

Talk to the study team

Anna Aulinas, MD PhD  ·  +34932919000  ·  aaulinas@santpau.cat

Alejandra Espinosa  ·  +34932919000  ·  aespinosag@santpau.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital de la Santa Creu i Sant PauBarcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07143266